{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T16:24:03Z","timestamp":1788452643605,"version":"build-2803163510"},"reference-count":102,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,6,27]],"date-time":"2024-06-27T00:00:00Z","timestamp":1719446400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["ebm-journal.org"],"crossmark-restriction":true},"short-container-title":["Exp. Biol. Med."],"abstract":"<jats:p>The cornea is an avascular tissue in the eye that has multiple functions in the eye to maintain clear vision which can significantly impair one\u2019s vision when subjected to damage. Peroxisome proliferator-activated receptors (PPARs), a family of nuclear receptor proteins comprising three different peroxisome proliferator-activated receptor (PPAR) isoforms, namely, PPAR alpha (\u03b1), PPAR gamma (\u03b3), and PPAR delta (\u03b4), have emerged as potential therapeutic targets for treating corneal diseases. In this review, we summarised the current literature on the therapeutic effects of PPAR agents on corneal diseases. We discussed the role of PPARs in the modulation of corneal wound healing, suppression of corneal inflammation, neovascularisation, fibrosis, stimulation of corneal nerve regeneration, and amelioration of dry eye by inhibiting oxidative stress within the cornea. We also discussed the underlying mechanisms of these therapeutic effects. Future clinical trials are warranted to further attest to the clinical therapeutic efficacy.<\/jats:p>","DOI":"10.3389\/ebm.2024.10142","type":"journal-article","created":{"date-parts":[[2024,6,27]],"date-time":"2024-06-27T12:37:38Z","timestamp":1719491858000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":10,"title":["Potential therapeutic effects of peroxisome proliferator-activated receptors on corneal diseases"],"prefix":"10.3389","volume":"249","author":[{"given":"Bing Jie","family":"Chow","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle Xin Yu","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Chi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,6,27]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/s0079-6336(01)80003-6","article-title":"Maintaining corneal integrity how the \u201cwindow\u201d stays clear","volume":"36","author":"Kurpakus-Wheater","year":"2001","journal-title":"Prog Histochem Cytochem"},{"key":"B2","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.jtos.2023.08.001","article-title":"Molecular nature of ocular surface barrier function, diseases that affect it, and its relevance for ocular drug delivery","volume":"30","author":"Kaur","year":"2023","journal-title":"Ocul Surf"},{"key":"B3","first-page":"214","article-title":"Corneal blindness: a global perspective","volume":"79","author":"Whitcher","year":"2001","journal-title":"Bull World Health Organ"},{"key":"B4","unstructured":"World report on vision \u2013Executive summary2024"},{"key":"B5","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1016\/s0014-4835(03)00050-2","article-title":"Corneal nerves: structure, contents and function","volume":"76","author":"M\u00fcller","year":"2003","journal-title":"Exp Eye Res"},{"key":"B6","doi-asserted-by":"publisher","first-page":"100762","DOI":"10.1016\/j.preteyeres.2019.05.003","article-title":"Corneal nerves in health and disease","volume":"73","author":"Al-Aqaba","year":"2019","journal-title":"Prog Retin Eye Res"},{"key":"B7","doi-asserted-by":"publisher","first-page":"2177","DOI":"10.4103\/1673-5374.308666","article-title":"Corneal neuromediator profiles following laser refractive surgery","volume":"16","author":"Yang","year":"2021","journal-title":"Neural Regen Res"},{"key":"B8","doi-asserted-by":"publisher","first-page":"2172","DOI":"10.4103\/1673-5374.327364","article-title":"Diabetic corneal neuropathy as a surrogate marker for diabetic peripheral neuropathy","volume":"17","author":"So","year":"2022","journal-title":"Neural Regen Res"},{"key":"B9","doi-asserted-by":"publisher","first-page":"516","DOI":"10.3928\/1081597x-20210423-01","article-title":"Tear neuromediator and corneal denervation following SMILE","volume":"37","author":"Chin","year":"2021","journal-title":"J Refract Surg"},{"key":"B10","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1161\/circulationaha.104.475673","article-title":"Peroxisome proliferator\u2013activated receptors as transcriptional nodal points and therapeutic targets","volume":"115","author":"Brown","year":"2007","journal-title":"Circulation"},{"key":"B11","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1210\/er.20.5.649","article-title":"Peroxisome proliferator-activated receptors: nuclear control of metabolism*","volume":"20","author":"Desvergne","year":"1999","journal-title":"Endocr Rev"},{"key":"B12","doi-asserted-by":"publisher","first-page":"13919","DOI":"10.1073\/pnas.241410198","article-title":"Structural determinants of ligand binding selectivity between the peroxisome proliferator-activated receptors","volume":"98","author":"Xu","year":"2001","journal-title":"Proc Natl Acad Sci"},{"key":"B13","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1038\/347645a0","article-title":"Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators","volume":"347","author":"Issemann","year":"1990","journal-title":"Nature"},{"key":"B14","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1161\/01.atv.0000015598.86369.04","article-title":"Pleiotropic actions of peroxisome proliferator\u2013activated receptors in lipid metabolism and atherosclerosis","volume":"22","author":"Barbier","year":"2002","journal-title":"Arteriosclerosis, Thromb Vasc Biol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"108617","DOI":"10.1016\/j.exer.2021.108617","article-title":"The role of peroxisome proliferator-activated receptors in healthy and diseased eyes","volume":"208","author":"Escandon","year":"2021","journal-title":"Exp Eye Res"},{"key":"B16","doi-asserted-by":"publisher","first-page":"860","DOI":"10.18240\/ijo.2020.06.02","article-title":"PPAR\u03b3: the dominant regulator among PPARs in dry eye lacrimal gland and diabetic lacrimal gland","volume":"13","author":"Mu","year":"2020","journal-title":"Int J Ophthalmol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"2201","DOI":"10.1210\/en.2003-0288","article-title":"Minireview: lipid metabolism, metabolic diseases, and peroxisome proliferator-activated receptors","volume":"144","author":"Lee","year":"2003","journal-title":"Endocrinology"},{"key":"B18","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1038\/ki.2009.330","article-title":"Transgenic expression of proximal tubule peroxisome proliferator\u2013activated receptor-\u03b1 in mice confers protection during acute kidney injury","volume":"76","author":"Li","year":"2009","journal-title":"Kidney Int"},{"key":"B19","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1002\/jcp.25804","article-title":"The role of various peroxisome proliferator-activated receptors and their ligands in clinical practice","volume":"233","author":"Derosa","year":"2018","journal-title":"J Cell Physiol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/13543776.2020.1703952","article-title":"Peroxisome proliferator-activated receptor agonists and antagonists: a patent review (2014-present)","volume":"30","author":"Takada","year":"2020","journal-title":"Expert Opin Ther Patents"},{"key":"B21","doi-asserted-by":"publisher","first-page":"4568","DOI":"10.1167\/iovs.13-13127","article-title":"Protective and antioxidant effects of PPAR\u03b1 in the ischemic retina","volume":"55","author":"Moran","year":"2014","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"B22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2008\/821592","article-title":"PPAR-\u0391 ligands as potential therapeutic agents for wet age-related macular degeneration","volume":"2008","author":"del V Cano","year":"2008","journal-title":"PPAR Res"},{"key":"B23","doi-asserted-by":"publisher","first-page":"15401","DOI":"10.1073\/pnas.1307211110","article-title":"Pathogenic role of diabetes-induced PPAR-\u03b1 down-regulation in microvascular dysfunction","volume":"110","author":"Hu","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B24","first-page":"1518","article-title":"Treatment of experimental autoimmune uveoretinitis with peroxisome proliferator-activated receptor \u03b1 agonist fenofibrate","volume":"20","author":"Osada","year":"2014","journal-title":"Mol Vis"},{"key":"B25","doi-asserted-by":"publisher","first-page":"e68935","DOI":"10.1371\/journal.pone.0068935","article-title":"The role of peroxisome proliferator-activated receptor and effects of its agonist, pioglitazone, on a rat model of optic nerve crush: PPAR\u03b3 in retinal neuroprotection","volume":"8","author":"Zhu","year":"2013","journal-title":"PLoS One"},{"key":"B26","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1007\/s13346-020-00843-z","article-title":"Corticosteroids in ophthalmology: drug delivery innovations, pharmacology, clinical applications, and future perspectives","volume":"11","author":"Gaballa","year":"2021","journal-title":"Drug Deliv Transl Res"},{"key":"B27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.survophthal.2019.07.001","article-title":"NSAID-induced corneal melt: clinical importance, pathogenesis, and risk mitigation","volume":"65","author":"Rigas","year":"2020","journal-title":"Surv Ophthalmol"},{"key":"B28","first-page":"1828","article-title":"Quiescent keratocytes fail to repair MMC induced DNA damage leading to the long-term inhibition of myofibroblast differentiation and wound healing","volume":"18","author":"Jester","year":"2012","journal-title":"Mol Vis"},{"key":"B29","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1016\/j.ajo.2020.04.036","article-title":"In vivo evaluation of corneal nerves and epithelial healing after treatment with recombinant nerve growth factor for neurotrophic keratopathy","volume":"217","author":"Mastropasqua","year":"2020","journal-title":"Am J Ophthalmol"},{"key":"B30","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1134\/s1068162023020139","article-title":"Drug repurposing: an effective tool in modern drug discovery","volume":"49","author":"Kulkarni","year":"2023","journal-title":"Russ J Bioorg Chem"},{"key":"B31","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1038\/labinvest.3700375","article-title":"TGF\u03b2 pathobiology in the eye","volume":"86","author":"Saika","year":"2006","journal-title":"Lab Invest"},{"key":"B32","doi-asserted-by":"publisher","first-page":"10081","DOI":"10.1002\/jcp.29823","article-title":"The proinflammatory cytokines IL-1\u03b2 and TNF-\u03b1 modulate corneal epithelial wound healing through p16Ink4a suppressing STAT3 activity","volume":"235","author":"Wang","year":"2020","journal-title":"J Cell Physiol"},{"key":"B33","doi-asserted-by":"publisher","first-page":"e2217576120","DOI":"10.1073\/pnas.2217576120","article-title":"Peroxisome proliferator-activated receptor-\u03b1 (PPAR\u03b1) regulates wound healing and mitochondrial metabolism in the cornea","volume":"120","author":"Liang","year":"2023","journal-title":"Proc Natl Acad Sci USA"},{"key":"B34","doi-asserted-by":"publisher","first-page":"C75","DOI":"10.1152\/ajpcell.00332.2006","article-title":"Effect of overexpression of ppar\u03b3 on the healing process of corneal alkali burn in mice","volume":"293","author":"Saika","year":"2007","journal-title":"Am J Physiology-Cell Physiol"},{"key":"B35","doi-asserted-by":"publisher","first-page":"88","DOI":"10.3390\/ph14020088","article-title":"Effects of selective peroxisome proliferator activated receptor agonists on corneal epithelial wound healing","volume":"14","author":"Tobita","year":"2021","journal-title":"Pharmaceuticals (Basel)"},{"key":"B36","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1016\/j.ajpath.2011.10.006","article-title":"Functional role of PPAR\u03b4 in corneal epithelial wound healing","volume":"180","author":"Nakamura","year":"2012","journal-title":"Am J Pathol"},{"key":"B37","doi-asserted-by":"publisher","first-page":"114","DOI":"10.3390\/molecules24010114","article-title":"PPAR\u03b1 agonist suppresses inflammation after corneal alkali burn by suppressing proinflammatory cytokines, MCP-1, and nuclear translocation of NF-\u03baB","volume":"24","author":"Nakano","year":"2018","journal-title":"Molecules"},{"key":"B38","doi-asserted-by":"publisher","first-page":"17763","DOI":"10.1038\/s41598-017-18113-3","article-title":"Peroxisome proliferator-activated receptor alpha agonist suppresses neovascularization by reducing both vascular endothelial growth factor and angiopoietin-2 in corneal alkali burn","volume":"7","author":"Arima","year":"2017","journal-title":"Sci Rep"},{"key":"B39","first-page":"2135","article-title":"An ophthalmic solution of a peroxisome proliferator-activated receptor gamma agonist prevents corneal inflammation in a rat alkali burn model","volume":"19","author":"Uchiyama","year":"2013","journal-title":"Mol Vis"},{"key":"B40","doi-asserted-by":"publisher","first-page":"5093","DOI":"10.3390\/ijms21145093","article-title":"Combination of peroxisome proliferator-activated receptor (PPAR) alpha and gamma agonists prevents corneal inflammation and neovascularization in a rat alkali burn model","volume":"21","author":"Nakano","year":"2020","journal-title":"Int J Mol Sci"},{"key":"B41","doi-asserted-by":"publisher","first-page":"5296","DOI":"10.3390\/ijms21155296","article-title":"Peroxisome proliferator-activated receptor beta\/delta agonist suppresses inflammation and promotes neovascularization","volume":"21","author":"Tobita","year":"2020","journal-title":"Int J Mol Sci"},{"key":"B42","doi-asserted-by":"publisher","first-page":"36703","DOI":"10.1074\/jbc.m004045200","article-title":"Induction of I\u03baB\u03b1 expression as a mechanism contributing to the anti-inflammatory activities of peroxisome proliferator-activated receptor-\u03b1 activators*","volume":"275","author":"Gervois","year":"2000","journal-title":"J Biol Chem"},{"key":"B43","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1189\/jlb.0602325","article-title":"The many faces of macrophage activation","volume":"73","author":"Mosser","year":"2003","journal-title":"J Leukoc Biol"},{"key":"B44","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.cmet.2007.06.010","article-title":"PPAR\u03b3 activation primes human monocytes into alternative M2 macrophages with anti-inflammatory properties","volume":"6","author":"Bouhlel","year":"2007","journal-title":"Cel Metab"},{"key":"B45","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1097\/01.lab.0000075642.11787.83","article-title":"Involvement of macrophage chemotactic protein-1 and interleukin-1\u03b2 during inflammatory but not basic fibroblast growth factor\u2013dependent neovascularization in the mouse cornea","volume":"83","author":"Yoshida","year":"2003","journal-title":"Lab Invest"},{"key":"B46","doi-asserted-by":"publisher","first-page":"108272","DOI":"10.1016\/j.exer.2020.108272","article-title":"Corneal myofibroblasts and fibrosis","volume":"201","author":"Wilson","year":"2020","journal-title":"Exp Eye Res"},{"key":"B47","doi-asserted-by":"publisher","first-page":"565","DOI":"10.2174\/1566524011009060565","article-title":"Role of transforming growth factor beta in corneal function, biology and pathology","volume":"10","author":"Tandon","year":"2010","journal-title":"Curr Mol Med"},{"key":"B48","doi-asserted-by":"publisher","first-page":"20841","DOI":"10.1038\/srep20841","article-title":"ITF2357 transactivates Id3 and regulate TGF\u03b2\/BMP7 signaling pathways to attenuate corneal fibrosis","volume":"6","author":"Lim","year":"2016","journal-title":"Sci Rep"},{"key":"B49","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/j.tcb.2009.05.008","article-title":"New regulatory mechanisms of TGF-\u03b2 receptor function","volume":"19","author":"Kang","year":"2009","journal-title":"Trends Cel Biol"},{"key":"B50","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1007\/s00441-011-1201-y","article-title":"Non-Smad signaling pathways","volume":"347","author":"Mu","year":"2012","journal-title":"Cell Tissue Res"},{"key":"B51","doi-asserted-by":"publisher","first-page":"e38827","DOI":"10.1371\/journal.pone.0038827","article-title":"Troglitazone attenuates TGF-\u03b21-induced EMT in alveolar epithelial cells via a ppar\u03b3-independent mechanism","volume":"7","author":"Zhou","year":"2012","journal-title":"PLoS One"},{"key":"B52","doi-asserted-by":"publisher","first-page":"e28915","DOI":"10.1371\/journal.pone.0028915","article-title":"Rosiglitazone inhibits transforming growth factor-\u03b21 mediated fibrogenesis in ADPKD cyst-lining epithelial cells","volume":"6","author":"Liu","year":"2011","journal-title":"PLoS One"},{"key":"B53","first-page":"2279","article-title":"Antifibrotic effect by activation of peroxisome proliferator-activated receptor\u2013\u03b3 in corneal fibroblasts","volume":"15","author":"Pan","year":"2009","journal-title":"Mol Vis"},{"key":"B54","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.exer.2015.06.028","article-title":"Inhibitory effects of PPAR\u03b3 ligands on TGF-\u03b21-induced CTGF expression in cat corneal fibroblasts","volume":"138","author":"Jeon","year":"2015","journal-title":"Exp Eye Res"},{"key":"B55","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1016\/j.ajpath.2014.01.026","article-title":"Inhibitory effects of PPAR\u03b3 ligands on TGF-\u03b21\u2013induced corneal myofibroblast transformation","volume":"184","author":"Jeon","year":"2014","journal-title":"Am J Pathol"},{"key":"B56","doi-asserted-by":"publisher","first-page":"1660","DOI":"10.1016\/j.ajpath.2017.04.002","article-title":"Antifibrotic actions of peroxisome proliferator-activated receptor \u03b3 ligands in corneal fibroblasts are mediated by \u03b2-catenin\u2013regulated pathways","volume":"187","author":"Jeon","year":"2017","journal-title":"Am J Pathol"},{"key":"B57","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1007\/s00417-021-05370-2","article-title":"Lobeglitazone attenuates fibrosis in corneal fibroblasts by interrupting TGF-beta-mediated Smad signaling","volume":"260","author":"Nuwormegbe","year":"2022","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"B58","doi-asserted-by":"publisher","first-page":"380","DOI":"10.3390\/metabo13030380","article-title":"Metabolomics in corneal diseases: a narrative review from clinical aspects","volume":"13","author":"Teo","year":"2023","journal-title":"Metabolites"},{"key":"B59","doi-asserted-by":"publisher","first-page":"3956","DOI":"10.3390\/jcm9123956","article-title":"Diabetic corneal neuropathy","volume":"9","author":"Mansoor","year":"2020","journal-title":"J Clin Med"},{"key":"B60","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.2337\/db19-0898","article-title":"Pathogenic role of PPAR\u03b1 downregulation in corneal nerve degeneration and impaired corneal sensitivity in diabetes","volume":"69","author":"Matlock","year":"2020","journal-title":"Diabetes"},{"key":"B61","first-page":"1220","article-title":"Evaluation of the effect of topical and oral peroxisome proliferator-activated receptor \u03b1 (PPAR\u03b1) agonist on corneal nerve regeneration in diabetic mice","volume":"63","author":"Mansoor","year":"2022","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"B102","doi-asserted-by":"publisher","first-page":"690","DOI":"10.4103\/1673-5374.289435","article-title":"Analysis of corneal nerve plexus in corneal confocal microscopy images","volume":"16","author":"Liu","year":"2021","journal-title":"Neural Regen Res"},{"key":"B62","doi-asserted-by":"publisher","first-page":"932","DOI":"10.2337\/db22-0611","article-title":"Oral peroxisome proliferator\u2013activated receptor-\u03b1 agonist enhances corneal nerve regeneration in patients with type 2 diabetes","volume":"72","author":"Teo","year":"2023","journal-title":"Diabetes"},{"key":"B63","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/1471-2202-7-45","article-title":"Activation of MAPK ERK in peripheral nerve after injury","volume":"7","author":"Agthong","year":"2006","journal-title":"BMC Neurosci"},{"key":"B64","first-page":"1484","article-title":"Chapter 33-complications of diabetes mellitus","volume-title":"Williams textbook of endocrinology (thirteenth edition)","author":"Brownlee","year":"2012"},{"key":"B65","doi-asserted-by":"publisher","first-page":"e87255","DOI":"10.1371\/journal.pone.0087255","article-title":"Increased axonal ribosome numbers is an early event in the pathogenesis of amyotrophic lateral sclerosis","volume":"9","author":"Verheijen","year":"2014","journal-title":"PLOS ONE"},{"key":"B66","doi-asserted-by":"publisher","first-page":"260","DOI":"10.2165\/00003495-199040020-00007","article-title":"Fenofibrate","volume":"40","author":"Balfour","year":"1990","journal-title":"Drugs"},{"key":"B67","doi-asserted-by":"publisher","first-page":"e68457","DOI":"10.7554\/elife.68457","article-title":"Profiling sensory neuron microenvironment after peripheral and central axon injury reveals key pathways for neural repair","volume":"10","author":"Avraham","year":"2021","journal-title":"Elife"},{"key":"B68","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.bbi.2021.01.004","article-title":"Targeting Peroxisome Proliferator-Activated Receptor-\u03b1 (PPAR- \u03b1) to reduce paclitaxel-induced peripheral neuropathy","volume":"93","author":"Caillaud","year":"2021","journal-title":"Brain Behav Immun"},{"key":"B69","doi-asserted-by":"publisher","first-page":"e83204","DOI":"10.1371\/journal.pone.0083204","article-title":"Therapeutic effects of fenofibrate on diabetic peripheral neuropathy by improving endothelial and neural survival in db\/db mice","volume":"9","author":"Cho","year":"2014","journal-title":"PLOS ONE"},{"key":"B70","doi-asserted-by":"publisher","first-page":"1849","DOI":"10.1016\/S0140-6736(05)67667-2","article-title":"Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): randomised controlled trial","volume":"366","author":"Keech","year":"2005","journal-title":"Lancet"},{"key":"B71","doi-asserted-by":"publisher","first-page":"2669","DOI":"10.1073\/pnas.0910658107","article-title":"Nuclear factor-\u03baB is a critical mediator of stress-impaired neurogenesis and depressive behavior","volume":"107","author":"Koo","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B72","doi-asserted-by":"publisher","first-page":"3933","DOI":"10.1523\/jneurosci.5646-03.2004","article-title":"A bioinformatics analysis of memory consolidation reveals involvement of the transcription factor c-rel","volume":"24","author":"Levenson","year":"2004","journal-title":"J Neurosci"},{"key":"B73","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1016\/j.tins.2011.03.001","article-title":"Regulation of neural process growth, elaboration and structural plasticity by NF-\u03baB","volume":"34","author":"Gutierrez","year":"2011","journal-title":"Trends Neurosciences"},{"key":"B74","doi-asserted-by":"publisher","first-page":"1835","DOI":"10.1111\/jdi.13535","article-title":"Association of platelet count and plateletcrit with nerve conduction function and peripheral neuropathy in patients with type 2 diabetes mellitus","volume":"12","author":"Qian","year":"2021","journal-title":"J Diabetes Invest"},{"key":"B75","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2020\/3509064","article-title":"Objective imaging diagnostics for dry eye disease","volume":"2020","author":"Han","year":"2020","journal-title":"J Ophthalmol"},{"key":"B76","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1016\/j.jtos.2017.05.008","article-title":"TFOS DEWS II definition and classification report","volume":"15","author":"Craig","year":"2017","journal-title":"Ocul Surf"},{"key":"B77","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1016\/j.jtos.2020.06.008","article-title":"Meibomian gland dysfunction is the primary determinant of dry eye symptoms: analysis of 2346 patients","volume":"18","author":"Teo","year":"2020","journal-title":"Ocul Surf"},{"key":"B78","doi-asserted-by":"publisher","first-page":"e412","DOI":"10.1111\/aos.13526","article-title":"Dry eye disease and oxidative stress","volume":"96","author":"Seen","year":"2018","journal-title":"Acta Ophthalmologica"},{"key":"B79","doi-asserted-by":"publisher","first-page":"875961","DOI":"10.1155\/2015\/875961","article-title":"New insights for oxidative stress and diabetes mellitus","volume":"2015","author":"Maiese","year":"2015","journal-title":"Oxidative Med Cell Longevity"},{"key":"B80","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2020\/8878172","article-title":"A review on oxidative stress, diabetic complications, and the roles of honey polyphenols","volume":"2020","author":"Pasupuleti","year":"2020","journal-title":"Oxidative Med Cell Longevity"},{"key":"B81","doi-asserted-by":"publisher","first-page":"109498","DOI":"10.1016\/j.exer.2023.109498","article-title":"Effect of PPAR\u03b3 on oxidative stress in diabetes-related dry eye","volume":"231","author":"Wang","year":"2023","journal-title":"Exp Eye Res"},{"key":"B82","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/s13098-019-0432-z","article-title":"Effect of rosiglitazone on inflammatory cytokines and oxidative stress after intensive insulin therapy in patients with newly diagnosed type 2 diabetes","volume":"11","author":"Li","year":"2019","journal-title":"Diabetology Metab Syndr"},{"key":"B83","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1111\/j.1755-3768.2019.5281","article-title":"Hyperlipidemia induces meibomian gland dysfunction","volume":"97","author":"Li","year":"2019","journal-title":"Acta Ophthalmologica"},{"key":"B84","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1167\/iovs.61.3.54","article-title":"PPAR-\u0391 agonist fenofibrate suppressed the formation of ocular surface squamous metaplasia induced by topical benzalkonium chloride","volume":"61","author":"He","year":"2020","journal-title":"Invest Opthalmology Vis Sci"},{"key":"B85","first-page":"2514","article-title":"Expression of vascular endothelial growth factor and its receptors in inflamed and vascularized human corneas","volume":"41","author":"Philipp","year":"2000","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"B86","doi-asserted-by":"publisher","first-page":"6691","DOI":"10.1167\/iovs.14-14746","article-title":"Keratocytes create stromal spaces to promote corneal neovascularization via MMP13 expression","volume":"55","author":"Ma","year":"2014","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"B87","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1038\/eye.2013.107","article-title":"Adverse events and complications associated with intravitreal injection of anti-VEGF agents: a review of literature","volume":"27","author":"Ghasemi Falavarjani","year":"2013","journal-title":"Eye (Lond)"},{"key":"B88","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1097\/00041433-200110000-00006","article-title":"Peroxisome proliferator-activated receptors in endothelial cell biology","volume":"12","author":"Plutzky","year":"2001","journal-title":"Curr Opin Lipidol"},{"key":"B89","doi-asserted-by":"publisher","first-page":"2709","DOI":"10.1016\/j.ajpath.2014.06.021","article-title":"Peroxisome proliferator\u2013activated receptor \u03b1 protects capillary pericytes in the retina","volume":"184","author":"Ding","year":"2014","journal-title":"Am J Pathol"},{"key":"B90","doi-asserted-by":"publisher","first-page":"107982","DOI":"10.1016\/j.exer.2020.107982","article-title":"Keratocytes promote corneal neovascularization through VEGFr3 induced by PPAR\u03b1-inhibition","volume":"193","author":"Wang","year":"2020","journal-title":"Exp Eye Res"},{"key":"B91","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1016\/j.exer.2004.10.009","article-title":"Inhibition of corneal neovascularization by a peroxisome proliferator-activated receptor-\u03b3 ligand","volume":"80","author":"Sarayba","year":"2005","journal-title":"Exp Eye Res"},{"key":"B92","doi-asserted-by":"publisher","first-page":"2177","DOI":"10.2165\/00003495-200464190-00003","article-title":"Role of fibric acid derivatives in the management of risk factors for coronary heart disease","volume":"64","author":"Despr\u00e9s","year":"2004","journal-title":"Drugs"},{"key":"B93","doi-asserted-by":"publisher","first-page":"2941","DOI":"10.1161\/01.cir.0000103683.99399.7e","article-title":"Thiazolidinedione use, fluid retention, and congestive heart failure","volume":"108","author":"Nesto","year":"2003","journal-title":"Circulation"},{"key":"B94","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1001\/archinternmed.2012.1938","article-title":"Association between thiazolidinedione treatment and risk of macular edema among patients with type 2 diabetes","volume":"172","author":"Idris","year":"2012","journal-title":"Arch Intern Med"},{"key":"B95","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.ajo.2017.12.007","article-title":"Lack of longitudinal association between thiazolidinediones and incidence and progression of diabetic eye disease: the ACCORD eye study","volume":"187","author":"Gower","year":"2018","journal-title":"Am J Ophthalmol"},{"key":"B96","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1001\/archophthalmol.2009.310","article-title":"Lack of association between thiazolidinediones and macular edema in type 2 diabetes: the ACCORD eye substudy","volume":"128","author":"Ambrosius","year":"2010","journal-title":"Arch Ophthalmol"},{"key":"B97","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1517\/14656566.2014.876992","article-title":"New peroxisome proliferator-activated receptor agonists: potential treatments for atherogenic dyslipidemia and non-alcoholic fatty liver disease","volume":"15","author":"Sahebkar","year":"2014","journal-title":"Expert Opin Pharmacother"},{"key":"B98","doi-asserted-by":"publisher","first-page":"47","DOI":"10.5497\/wjp.v2.i2.47","article-title":"Ocular drug delivery systems: an overview","volume":"2","author":"Patel","year":"2013","journal-title":"World J Pharmacol"},{"key":"B99","doi-asserted-by":"publisher","first-page":"277","DOI":"10.3390\/jfb6020277","article-title":"Nanomedicine approaches for corneal diseases","volume":"6","author":"Chaurasia","year":"2015","journal-title":"J Funct Biomater"},{"key":"B100","doi-asserted-by":"publisher","first-page":"351","DOI":"10.3390\/ph13110351","article-title":"Nanotechnology for the treatment of allergic conjunctival diseases","volume":"13","author":"Liu","year":"2020","journal-title":"Pharmaceuticals (Basel)"},{"key":"B101","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.3390\/pharmaceutics15051452","article-title":"PPAR-\u0393 agonist GW1929 targeted to macrophages with dendrimer\u2013graphene nanostars reduces liver fibrosis and inflammation","volume":"15","author":"Moreno-Lanceta","year":"2023","journal-title":"Pharmaceutics"}],"container-title":["Experimental Biology and Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.ebm-journal.org\/articles\/10.3389\/ebm.2024.10142\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,27]],"date-time":"2024-06-27T12:37:48Z","timestamp":1719491868000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ebm-journal.org\/articles\/10.3389\/ebm.2024.10142\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,27]]},"references-count":102,"alternative-id":["10.3389\/ebm.2024.10142"],"URL":"https:\/\/doi.org\/10.3389\/ebm.2024.10142","relation":{},"ISSN":["1535-3699"],"issn-type":[{"value":"1535-3699","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,27]]},"article-number":"10142"}}